BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 18556388)

  • 1. Hepcidin is linked to anemia and inflammation in peritoneal dialysis patients.
    Malyszko J; Malyszko JS; Pawlak K; Drozdowska-Rams L; Brzosko S; Mysliwiec M
    Perit Dial Int; 2008; 28(4):418-21. PubMed ID: 18556388
    [No Abstract]   [Full Text] [Related]  

  • 2. Greater potency of darbepoetin-α than erythropoietin in suppression of serum hepcidin-25 and utilization of iron for erythropoiesis in hemodialysis patients.
    Shoji S; Inaba M; Tomosugi N; Okuno S; Ichii M; Yamakawa T; Kurihara S
    Eur J Haematol; 2013 Mar; 90(3):237-44. PubMed ID: 23281632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepcidin in anemia and inflammation in chronic kidney disease.
    Malyszko J; Mysliwiec M
    Kidney Blood Press Res; 2007; 30(1):15-30. PubMed ID: 17215586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is hepcidin the star player in iron metabolism in chronic kidney disease?
    Hamada Y; Fukagawa M
    Kidney Int; 2009 May; 75(9):873-4. PubMed ID: 19367309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iron sequestration and anemia of inflammation.
    Ganz T; Nemeth E
    Semin Hematol; 2009 Oct; 46(4):387-93. PubMed ID: 19786207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepcidin serum levels and resistance to recombinant human erythropoietin therapy in haemodialysis patients.
    Costa E; Swinkels DW; Laarakkers CM; Rocha-Pereira P; Rocha S; Reis F; Teixeira F; Miranda V; do Sameiro Faria M; Loureiro A; Quintanilha A; Belo L; Santos-Silva A
    Acta Haematol; 2009; 122(4):226-9. PubMed ID: 19887781
    [No Abstract]   [Full Text] [Related]  

  • 7. Hepcidin and regulation of iron homeostasis in maintenance hemodialysis patients.
    Sany D; Elsawy AE; Elshahawy Y
    Saudi J Kidney Dis Transpl; 2014 Sep; 25(5):967-73. PubMed ID: 25193892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepcidin: a new tool in the management of anaemia in patients with chronic kidney disease?
    Swinkels DW; Wetzels JF
    Nephrol Dial Transplant; 2008 Aug; 23(8):2450-3. PubMed ID: 18495744
    [No Abstract]   [Full Text] [Related]  

  • 9. New developments in anemia management in chronic kidney disease.
    Amerling R; Besarab A; Roy C
    Nephrol News Issues; 2008 Mar; 22(3):suppl 1-8. PubMed ID: 18372676
    [No Abstract]   [Full Text] [Related]  

  • 10. The anemia of inflammation.
    Stein BL
    J Clin Rheumatol; 2012 Dec; 18(8):437-42. PubMed ID: 23211586
    [No Abstract]   [Full Text] [Related]  

  • 11. Hyporesponsiveness to erythropoietin therapy in hemodialyzed patients: potential role of prohepcidin, hepcidin, and inflammation.
    Malyszko J; Malyszko JS; Mysliwiec M
    Ren Fail; 2009; 31(7):544-8. PubMed ID: 19839848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is hepcidin a link between anemia, inflammation and liver function in hemodialyzed patients?
    Małyszko J; Małyszko JS; Hryszko T; Pawlak K; Mysliwiec M
    Am J Nephrol; 2005; 25(6):586-90. PubMed ID: 16254410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of a pharmacist-implemented anemia management protocol in an outpatient hemodialysis unit.
    To LL; Stoner CP; Stolley SN; Buenviaje JD; Ziegler TW
    Am J Health Syst Pharm; 2001 Nov; 58(21):2061-5. PubMed ID: 11715828
    [No Abstract]   [Full Text] [Related]  

  • 14. Erythropoietic agents in peritoneal dialysis.
    Muirhead N
    Perit Dial Int; 2005; 25(6):547-50. PubMed ID: 16411519
    [No Abstract]   [Full Text] [Related]  

  • 15. Plasma hepcidin levels are elevated but responsive to erythropoietin therapy in renal disease.
    Ashby DR; Gale DP; Busbridge M; Murphy KG; Duncan ND; Cairns TD; Taube DH; Bloom SR; Tam FW; Chapman RS; Maxwell PH; Choi P
    Kidney Int; 2009 May; 75(9):976-81. PubMed ID: 19212416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anemia in chronic kidney disease: new advances.
    Patel TV; Singh AK
    Heart Fail Clin; 2010 Jul; 6(3):347-57. PubMed ID: 20630409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepcidin and iron status among pregnant women in Bangladesh.
    Schulze KJ; Christian P; Ruczinski I; Ray AL; Nath A; Wu LS; Semba RD
    Asia Pac J Clin Nutr; 2008; 17(3):451-6. PubMed ID: 18818166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepcidin in iron metabolism.
    Ganz T
    Curr Opin Hematol; 2004 Jul; 11(4):251-4. PubMed ID: 15314524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum hepcidin-25 levels and anemia in non-dialysis chronic kidney disease patients: a cross-sectional study.
    Uehata T; Tomosugi N; Shoji T; Sakaguchi Y; Suzuki A; Kaneko T; Okada N; Yamamoto R; Nagasawa Y; Kato K; Isaka Y; Rakugi H; Tsubakihara Y
    Nephrol Dial Transplant; 2012 Mar; 27(3):1076-83. PubMed ID: 21799206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepcidin the link between inflammation and anemia in chronic renal failure.
    Atanasiu V; Manolescu B; Stoian I
    Rom J Intern Med; 2006; 44(1):25-33. PubMed ID: 17236285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.